Granulin Antikörper
-
- Target Alle Granulin (GRN) Antikörper anzeigen
- Granulin (GRN)
-
Reaktivität
- Human
-
Wirt
-
Meerschweinchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Granulin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Spezifität
- Recognizes human progranulin. Detects a band of ~90 kDa by Western blot.
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Weakly cross-reacts with mouse progranulin. Cross-reacts with hGRN-C and hGRN-F.
- Sterilität
- 0.2 μm filtered
- Immunogen
- Recombinant human progranulin.
- Top Product
- Discover our top product GRN Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at -20°C. - Haltbarkeit
- 6 months
-
- Target
- Granulin (GRN)
- Andere Bezeichnung
- Progranulin (GRN Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- Progranulin (PGRN) is a widely expressed pluripotent growth factor which plays a role in processes such as development, wound repair and inflammation by activating signaling cascades that control cell cycle progression and cell motility. Its function in the central nervous system is of interest, as mutations in the PGRN gene were found in cases of frontotemporal degeneration (FTLD). In addition, PGRN has also been linked to tumorigenesis. Progranulin is a biomarker for FTLD, other types of Alzheimer's Disease (AD) and potentially for MCI (Mild Cognitive Impairment). Additionally, PGRN is described as a new ligand of TNF receptors and a potential therapeutic against inflammatory disease like arthritis.
- UniProt
- P28799
-